FDA NDC Directory · JSON-LD · Markdown

CAVHANZA

NDC 70709-192 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING

Generic nameNilotinib
Labeler / ManufacturerCycle Pharmaceuticals Ltd
Marketing categoryNew Drug Application (innovator) · App NDA217379
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsNILOTINIB (80 mg/1)
Marketing started20260630
Package count1

External sources

Source: openFDA. Public-domain (CC0).